Clinical Trial

Meir Medical Center Rheumatologic Biobank

Recruiting
View on ClinicalTrials.gov →
Summary
Serum, synovial fluid and skin biopsies from patients will be collected to the biobank with rheumatoid diseases. These samples will later be used for clinical and basic research, following approval of each specific study by the IRB. The investigators intend to extract protein, DNA and RNA from each sample.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2018-03-21.
Status change: Not Yet Recruiting → Recruiting 2019-03-07
Trial Details
NCT Number NCT03473912
Lead Sponsor Meir Medical Center
Conditions Rheumatoid Arthritis, Lupus Erythematosus, Systemic, Systemic Sclerosis, IgG4-related Disease, Sjogren's Syndrome
Enrollment 500 participants
Start Date 2018-04-16
Primary Completion 2037-11 (estimated)
Study Completion 2037-11 (estimated)
Updated on ClinicalTrials.gov 2019-03-11